94448-8
HLA-DP and DQ and DR (class II) IgG intermediate risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
Active
Term Description
Laboratories that perform HLA antibody testing often report the specific antibodies found in categories based on the "amount" of each antibody found (called mean fluorescent intensity, MFI, for the common Luminex bead method). Theoretically, the antibodies present in higher concentrations, which are more likely to react with donor antigens, will have higher MFI values. Since risk stratification based on MFI range is not standardized and the exact cutoffs vary from lab to lab, this term is intended to report those HLA antibodies found in an intermediate risk stratification of MFI values (For one lab this was 4999 > MFI > 2000, but some laboratories use other values).
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- HLA-DP & DQ & DR (class II) Ab.IgG intermediate risk
- Property
- Prid
- Time
- Pt
- System
- Ser/Plas
- Scale
- Nom
- Method
- Flow cytometry
Additional Names
- Short Name
- HLA class II Ab.IgG med risk SerPl FC
- Display Name
- HLA-DP & DQ & DR (class II) Ab.IgG intermediate risk FC Nom
- Consumer Name Alpha Get Info
- HLA-DP & DQ & DR (class II) Ab.IgG intermediate risk, Blood
Example Answer List: LL3602-1
Source: NCBI PubMedAnswer | Code | Score | Answer ID |
---|---|---|---|
Anti-DP1 | LA23895-8 | ||
Anti-DP2 | LA23894-1 | ||
Anti-DP3 | LA23897-4 | ||
Anti-DP4 | LA23896-6 | ||
Anti-DP5 | LA23898-2 | ||
Anti-DP6 | LA23899-0 | ||
Anti-DQ1 | LA23909-7 | ||
Anti-DQ2 | LA23906-3 | ||
Anti-DQ3 | LA23907-1 | ||
Anti-DQ4 | LA23908-9 | ||
Anti-DQ5(1) | LA23903-0 | ||
Anti-DQ6(1) | LA23902-2 | ||
Anti-DQ7(3) | LA23904-8 | ||
Anti-DQ8(3) | LA23905-5 | ||
Anti-DR1 | LA23910-5 | ||
Anti-DR3 | LA23914-7 | ||
Anti-DR4 | LA23915-4 | ||
Anti-DR6 | LA23922-0 | ||
Anti-DR7 | LA23916-2 | ||
Anti-DR8 | LA23917-0 | ||
Anti-DR10 | LA23918-8 | ||
Anti-DR11(5) | LA23919-6 | ||
Anti-DR12(5) | LA23920-4 | ||
Anti-DR13(6) | LA23921-2 | ||
Anti-DR14(6) | LA23923-8 | ||
Anti-DR15(2) | LA23924-6 | ||
Anti-DR16(2) | LA23925-3 | ||
Anti-DR17(3) | LA23912-1 | ||
Anti-DR18(3) | LA23913-9 | ||
Anti-DR51 | LA23927-9 | ||
Anti-DR52 | LA23926-1 | ||
Anti-DR53 | LA23928-7 | ||
Anti-DR103 | LA23911-3 |
Basic Attributes
- Class
- HLA
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.68
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
94428-0 | HLA class I and II IgG panel - Serum or Plasma by Flow cytometry (FC) |
94440-5 | HLA-DP and DQ and DR (class II) IgG panel - Serum or Plasma by Flow cytometry (FC) |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | HLA-DP, DQ, DR (class II) riesgo intermedio por Ac IgG: |
es-MX | Spanish (Mexico) | HLA-DP & DQ & DR (clase II) Ab.IgG riesgo intermedio: |
fr-FR | French (France) | HLA-DP et DQ et DR (classe II) anticorps IgG MFI moyenne: |
it-IT | Italian (Italy) | HLA-DP & DQ & DR (classe II) Ab.IgG, rischio intermedio: Synonyms: Citometria a flusso (FC) HLA tipizzazione tissutale antigeni-anticorpi HLA-DP e DQ e DR (classe II) Plasma Presenza o Identità Pressione differenziale Punto nel tempo (episodio) Rischio intermedio di HLA-DP e DQ e DR (classe II) IgG Siero Siero o Plasma |
nl-NL | Dutch (Netherlands) | HLA-DP & DQ & DR (klasse II) As.IgG intermediair risico: |
pl-PL | Polish (Poland) | HLA-DP & DQ & DR (klasa II) Ab.IgG średniego ryzyka: Synonyms: IgG Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) średniego ryzyka |
zh-CN | Chinese (China) | HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 中度风险: Synonyms: HLA II 类; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=94448-8
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright